Pillstats
Rx only · Injection, Solution · Intravenous

Tirofiban

Brands: Aggrastat · Tirofiban Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)73137
US makers3 labelers
Packages9
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a122435472025 Q12025 Q22025 Q32025 Q42026 Q1
18
Rx · 2025 Q4
170
Units dispensed
4
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Medicure International Incunknown6SUPPLYING
Eugia US LLCunknown2SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 21, 2025
    RECALLRecall (Class II): Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in…

    Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances. — Recalling firm: Eugia US LLC — USA nationwide.

  • Apr 21, 2025
    RECALLRecall (Class II): Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured…

    Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances. — Recalling firm: Eugia US LLC — USA nationwide.